[The 8p11 myeloproliferative syndrome]

Area of Science:

• Hematology
• Oncology
• Molecular Genetics

Context:

• The 8p11 myeloproliferative syndrome is a rare hematologic malignancy.
• It presents with chronic myelogenous leukemia-like features, eosinophilia, and a high incidence of T-lymphoblastic lymphoma.
• The disease has a short chronic phase followed by rapid transformation to acute myelogenous leukemia, with a median survival under 12 months.

Purpose:

• To investigate the cytogenetic and molecular basis of the 8p11 myeloproliferative syndrome.
• To identify the genetic alterations leading to the activation of tyrosine kinase pathways in this condition.

Summary:

• The 8p11 myeloproliferative syndrome is characterized by myeloid hyperplasia, eosinophilia, and non-Hodgkin's lymphoma.
• Cytogenetically, it involves specific translocations at chromosome band 8p11, including t(8;13), t(8;9), and t(6;8).
• Molecularly, these translocations result in fusion genes involving the fibroblast growth factor receptor-1 (FGFR1) gene, leading to its activation.

Impact:

• Understanding the role of FGFR1 activation in this syndrome.
• Highlights the importance of tyrosine kinase signaling in myeloproliferative disorders.
• Suggests tyrosine kinase inhibitors as a potential therapeutic strategy for 8p11 myeloproliferative syndrome and related disorders.